首页|氨溴索联合纤支镜灌洗治疗重症肺炎患者的效果

氨溴索联合纤支镜灌洗治疗重症肺炎患者的效果

扫码查看
目的:观察氨溴索联合纤支镜灌洗治疗重症肺炎患者的效果.方法:选取 2021 年 1 月至 2023 年 1 月该院收治的 92 例重症肺炎患者进行前瞻性研究,按照随机数字表法将其分为研究组和对照组各 46 例.对照组采用纤支镜灌洗治疗,研究组在对照组基础上联合氨溴索治疗,比较两组临床疗效、临床症状消失时间,治疗前后炎性因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)、降钙素原(PCT)]水平、肺功能指标[第 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)、每分通气量(MV)]水平,以及不良反应发生率.结果:研究组治疗总有效率为 89.13%(41/46),高于对照组的 71.74%(33/46),差异有统计学意义(P<0.05);研究组止咳时间、退热时间和肺啰音消失时间均短于对照组,差异有统计学意义(P<0.05);治疗后,两组PCT、CRP和IL-6 水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);治疗后,两组FEV1、FVC、MV水平均高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:氨溴索联合纤支镜灌洗治疗重症肺炎患者可提高治疗总有效率和肺功能指标水平,缩短临床症状消失时间,降低炎性因子水平,其效果优于单纯纤支镜灌洗治疗.
Effects of Ambroxol combined with fiberoptic bronchoscopy suction lavage in the treatment of patients with severe pneumonia
Objective:To observe effects of Ambroxol combined with fiberoptic bronchoscopy suction lavage in treatment of patients with severe pneumonia.Methods:A prospective study was conducted on 92 patients with severe pneumonia admitted to the hospital from January 2021 to January 2023.According to the random number table method,they were divided into study group and control group,46 cases in each group.The control group was treated with fiberoptic bronchoscopy suction lavage,while the study group was treated with Ambroxol on the basis of that of the control group.The clinical efficacy,the disappearance time of clinical symptoms,the levels of inflammatory factors[C-reactive protein(CRP),interleukin-6(IL-6),procalcitonin(PCT)]and lung function indexes[forced expiratory volume in one second(FEV1),forced vital capacity(FVC),minute ventilation(MV)]before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 89.13%(41/46),which was higher than 71.74%(33/46)of the control group,and the difference was statistically significant(P<0.05).The cough time,the antipyretic time and the lung rale disappearance time in the study group were shorter than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of PCT,CRP and IL-6 in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of FEV1,FVC and MV in the two groups were higher than those before the treatment,those in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Ambroxol combined with fiberoptic bronchoscopy suction lavage in the treatment of the patients with severe pneumonia can improve the total effective rate of treatment and the levels of lung function indexes,shorten the disappearance time of clinical symptoms,and reduce the levels of inflammatory factors.Moreover,it is superior to simple fiberoptic bronchoscopy suction lavage treatment.

AmbroxolFiberoptic bronchoscopy suction lavageSevere pneumoniaLung functionInflammatory factorAdverse reaction

张南、张金献、杨素素

展开 >

平顶山河舞总医院呼吸与危重症科二病区,河南 平顶山 462500

氨溴索 纤支镜吸痰灌洗 重症肺炎 肺功能 炎性因子 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(19)